MXCT vs PLD · rev $38.6M vs P/E 27, rev $8.79B
MaxCyte Inc (MXCT) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
MXCT currently screens at market cap $124.3M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the MXCT and PLD stock pages for the full models.
Not investment advice.